Cefarka T 1000mg/125mg Injection
Marketer
Mediarka Lifesciences Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Cefarka T 1000mg/125mg Injection
Cefarka T, a 1000mg/125mg injectable combination drug, combats bacterial infections by inhibiting microbial growth and propagation. Administration must be under a doctor's direct supervision; strict adherence to the prescribed dosage schedule is crucial for complete treatment, even with symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms require immediate medical attention. Seek immediate medical assistance for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all current medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving, avoid operating vehicles if drowsiness or dizziness occurs. Rest, a balanced diet, and adequate hydration promote recovery. Your doctor may order tests to monitor the drug's effects.
Primary Ingredients of Cefarka T 1000mg/125mg Injection
No information provided. Please provide the text you wish to be rewritten.
Uses of Cefarka T 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Cefarka T 1000mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefarka T 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefarka T 1000mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cefarka T 1000mg/125mg Injection works:
Ceftriaxone and Tazobactum, combined as Cefarka T 1000mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, thereby hindering bacterial growth and survival. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial defenses, augmenting Ceftriaxone's effectiveness and broadening its antibacterial spectrum.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Cefarka T 1000mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefarka T (1000mg/125mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Cefarka T 1000mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefarka T 1000mg/125mg Injection can lead to reduced awareness, impaired vision, drowsiness, and dizziness. Driving should be avoided if these side effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefarka T 1000mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Cefarka T (1000mg/125mg) requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Cefarka T (1000mg/125mg) injection is not suggested for patients experiencing mild or moderate liver dysfunction.
What if you forget to take Cefarka T 1000mg/125mg Injection :
Omit a dose of Cefarka T 1000mg/125mg Injection? Seek immediate medical advice.
Facts to Know About Cefarka T 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently